UNS:Novel biomaterials with light-controlled CO release for modulation of endothelial cells
UNS:Novel biomaterials with light-controlled CO release for modulation of endothelial cells
批准号:
1510003
负责人:
Christopher Bashur
金额:
$35.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-15 至 2019-05-31
中文摘要
[1510003] Christopher a . Bashur,该奖项的长期目标是开展新的组织工程支架的基础研究,以提高外周动脉疾病患者的移植物存活率。超过30%的患者没有可用于移植手术的存活静脉。在这个奖项中,从纤维支架中控制一氧化碳(CO)的递送代表了治疗外周动脉疾病的独特组织工程方法。该奖项既支持生成血管移植物的初始步骤,也支持更好地了解细胞对支架反应的基础科学工作。此外,这项研究将与本科生和研究生的培训结合起来,包括那些来自代表性不足群体的学生。该研究的具体目的是确定在细胞培养中促进内皮细胞增殖的组织工程支架成分。所提出的支架的一个变革性特征是独特的光活化CO释放分子(photoCORM)的结合。这种策略提供了一种纤维支架,能够控制自然发生的生物信号分子(如一氧化碳)向周围细胞的传递。具体任务包括:(a)确定支持该photoCORM技术的电纺丝支架组合物,(b)研究局部CO剂量大小和时间如何影响内皮细胞功能,以及(c)设计和合成新型photoCORM以更有效地递送CO。内皮细胞可以单独培养,也可以共培养,更能代表体内环境。这项基础研究的应用包括外周动脉疾病的治疗。该奖项由CBET生物技术与生化工程项目颁发,由材料研究部生物材料项目共同资助。
英文摘要
1510003 Bashur, Christopher A.The long-term objective of this award is to conduct fundamental research into new tissue engineered scaffolds that that could improve graft viability in patients with peripheral artery disease. More than 30% of these patients do not have viable veins that can be used for graft surgeries. The controlled delivery of carbonmonoxide (CO) from a fibrous scaffold in this award represents a unique tissue engineering approach for treating peripheral artery disease. This award supports both the initial steps in generating the vascular graft and the basic science work to better understand the cells response to the scaffold. In addition, this research will be integrated with training of undergraduate and graduate students, including those from underrepresented groups. The specific objective of the proposed research is to determine tissue engineered scaffold compositions that promote endothelial cell proliferation in cell culture. One transformative feature of the proposed scaffold is the incorporation of unique photoactivated CO releasing molecules (photoCORM). This strategy provides a fibrous scaffold with the ability to control delivery of a naturally occurring biological signaling molecule such as carbon monoxide to the surrounding cells. The specific tasks include: (a) determining electrospun scaffold compositions that support this photoCORM technology, (b) investigating how localized CO dose magnitude and timing impacts endothelial cell function, and (c) designing and synthesizing novel photoCORMs for more effective CO delivery. The endothelial cells will be cultured both by themselves and in co-culture, which is more representative of the environment in the body. The applications of this fundamental research include treatment for peripheral artery disease.This award by the Biotechnology and Biochemical Engineering Program of CBET is co-funded by the Biomaterials Program of the Division of Materials Research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: